abstract |
The present invention treats, prevents and/or reduces the risk of diseases, disorders or conditions whose pathogenesis is associated with aldehyde toxicity, including ocular disorders, skin disorders, conditions associated with adverse effects from vesicants, and autoimmune, inflammatory, neurological and cardiovascular diseases. |